Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo. uri icon

authors

  • Steele, John W
  • Bezprozvanny, Ilya
  • Ehrlich, Michelle E
  • David M. Holtzman, MD
  • Gandy, Sam
  • Kim, Soong H
  • Cirrito, John R
  • Verges, Deborah K
  • Restivo, Jessica L
  • Westaway, David
  • Fraser, Paul
  • Hyslop, Peter St George
  • Sano, Mary

publication date

  • January 1, 2009